Life Sciences Alternative Funding LLC 13D and 13G filings for Biodesix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 07:30 am Sale |
2024-09-30 | 13G | Biodesix, Inc. BDSX |
Life Sciences Alternative Funding LLC | 2,180,514 1.500% |
-9,913 (-0.45%) |
Filing |
| 2021-05-28 6:03 pm Purchase |
2020-12-31 | 13G | Biodesix, Inc. BDSX |
Life Sciences Alternative Funding LLC | 2,190,427 8.200% |
2,190,427 (New Position) |
Filing |